Skip to main navigation Skip to search Skip to main content

The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype

  • Barry Iacopetta
  • , F. Grieu
  • , D. Joseph

Research output: Contribution to journalArticlepeer-review

Abstract

Serum and tissue levels of interleukin-6 (IL-6) have been implicated in the biological phenotype of breast carcinoma. A common G/C polymorphism at position -174 of the IL-6 promoter can influence the expression level of this gene. We therefore investigated for associations between this polymorphism and various phenotypic features in a series of 256 breast cancers. Individuals who were homozygous for the C allele (n = 55) were more likely to have higher-grade tumours (P = 0.039) with ductal histology (P = 0.030) compared to those harbouring at least one wild-type G allele (n = 201). Homozygosity for the C allele was also associated with significantly worse overall survival (P = 0.031). We conclude that the -174 C allele of IL-6 is associated with a more aggressive breast cancer phenotype.
Original languageEnglish
Pages (from-to)419-422
JournalBritish Journal of Cancer
Volume90
Issue number2
DOIs
Publication statusPublished - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype'. Together they form a unique fingerprint.

Cite this